Holtermann Leonie, Rivera-Galdos Ronmy, Nottebaum Astrid F, Wessel Florian, Ipe Ute, Vestweber Dietmar
Department of Vascular Cell Biology, Max Planck Institute for Molecular Biomedicine, Röntgenstrasse 20, 48149, Münster, Germany.
Cell Mol Life Sci. 2025 Jun 5;82(1):223. doi: 10.1007/s00018-025-05753-2.
VE-cadherin is a major component of endothelial adherens junctions and pivotal to the regulation of vascular barrier integrity. Whereas two phosphorylation sites of VE-cadherin (Y685 and Y731) are known to be relevant for the regulation of endothelial junctions in vivo, several others were suggested to be relevant based on in vitro studies. Here, we analyze for two of these, serine 665 (S665) and tyrosine 658 (Y658), whether they are relevant for the induction of vascular permeability in vivo. To this end, we generated and characterized two point-mutated VE-cadherin knock-in mouse lines where either S665 was replaced by valine (S665V) or Y658 by phenylalanine (Y658F). We found that the induction of vascular permeability by histamine or VEGF in the skin was clearly reduced in S665V mice, whereas Y658F mice showed a normal increase of permeability. In line with this, we found that histamine-induced endocytosis was impaired for the VE-cadherin-S665V mutant, but not for the Y658F mutant. Comparing the regulation of VE-cadherin phosphorylation at S665, Y658 and Y685, we found that only phosphorylation of S665 and Y685 were strongly induced by inflammatory mediators, while phosphorylation of Y658 increased weakly. Interestingly, phosphorylation of S665 and Y685 occurred with different kinetics, but independent of each other. Collectively, our results demonstrate that Y658 is irrelevant for vascular leak formation in the context of several tested inflammatory mediators and establish S665 of VE-cadherin as an important phosphorylation site regulating the induction of endothelial permeability in vivo.
血管内皮钙黏蛋白是内皮细胞黏附连接的主要成分,对血管屏障完整性的调节至关重要。已知血管内皮钙黏蛋白的两个磷酸化位点(Y685和Y731)与体内内皮连接的调节相关,基于体外研究还提出了其他几个相关位点。在此,我们分析其中两个位点,即丝氨酸665(S665)和酪氨酸658(Y658),是否与体内血管通透性的诱导相关。为此,我们构建并鉴定了两个点突变的血管内皮钙黏蛋白基因敲入小鼠品系,其中S665被缬氨酸取代(S665V),Y658被苯丙氨酸取代(Y658F)。我们发现,组胺或血管内皮生长因子(VEGF)诱导的皮肤血管通透性在S665V小鼠中明显降低,而Y658F小鼠的通透性正常增加。与此一致,我们发现组胺诱导的内吞作用在血管内皮钙黏蛋白-S665V突变体中受损,但在Y658F突变体中未受损。比较S665、Y658和Y685处血管内皮钙黏蛋白磷酸化的调节情况,我们发现只有S665和Y685的磷酸化被炎症介质强烈诱导,而Y658的磷酸化增加较弱。有趣的是,S665和Y685的磷酸化发生动力学不同,但相互独立。总体而言,我们的结果表明,在几种测试的炎症介质背景下,Y658与血管渗漏形成无关,并确定血管内皮钙黏蛋白的S665是调节体内内皮通透性诱导的重要磷酸化位点。